Your session is about to expire
← Back to Search
Emergency Preparedness Training for Dementia Caregiving (DPW-Caregiver Trial)
N/A
Recruiting
Led By Sato Ashida, PhD
Research Sponsored by Sato Ashida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change between baseline and 6-month follow-up
Awards & highlights
DPW-Caregiver Trial Summary
This trial seeks to help caregivers of persons with dementia develop emergency care plans & support networks to increase resilience & reduce distress during disasters.
Who is the study for?
This trial is for English-speaking adults who are family members or friends caring for someone with Alzheimer's disease or related dementias (ADRD). Caregivers can participate regardless of living situation with the individual. Excluded are caregivers of those in early stages like predementia, those in nursing homes, and anyone unable to consent or respond due to their own conditions.Check my eligibility
What is being tested?
The study tests 'Disaster PrepWise', a program where trained volunteers help caregivers create emergency plans and support networks. The impact on caregiver resilience and stress will be measured against an information-only group. Assessments will occur at baseline, 3 months, and 6 months post-baseline.See study design
What are the potential side effects?
Since this intervention involves educational guidance rather than medical treatment, traditional side effects aren't expected. However, participants may experience varying levels of emotional distress or anxiety when considering disaster scenarios during planning.
DPW-Caregiver Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change between baseline and 6-month follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change between baseline and 6-month follow-up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Caregiver stress
Resilience
Secondary outcome measures
Caregiver Preparedness
Self-Efficacy
Social Networks
DPW-Caregiver Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Disaster PrepWise-Caregiver InterventionExperimental Treatment1 Intervention
Caregivers who consent to participate, complete a baseline survey, and are assigned to the intervention arm will receive a Disaster PrepWise-Caregiver program from a trained interventionist and receive a completed household emergency management plan. Control participants will complete follow-up surveys at 3 and 6 months, similar to intervention participants.
Group II: ControlActive Control1 Intervention
Caregivers who consent to participate, complete a baseline survey, and are assigned to the control arm will receive a four-page handout on Emergency Preparedness published by the Alzheimer's Association that provides tips on preparing for disasters and what to do during and after a disaster. Control participants will complete follow-up surveys at 3 and 6 months, similar to intervention participants.
Find a Location
Who is running the clinical trial?
Sato AshidaLead Sponsor
1 Previous Clinical Trials
82 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,674 Previous Clinical Trials
28,020,705 Total Patients Enrolled
4 Trials studying Caregiver Stress
685 Patients Enrolled for Caregiver Stress
Sato Ashida, PhDPrincipal InvestigatorUniversity of Iowa
1 Previous Clinical Trials
82 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My family member does not have predementia or mild cognitive impairment.I am 18 or older and speak English.I am a family member or friend of someone with Alzheimer's or related dementia.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Disaster PrepWise-Caregiver Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Have enrollment requirements for this trial been established yet?
"Based on the information found at clinicaltrials.gov, this research study is not currently open to participant enrolment. It was initially posted March 1st 2023 and edited November 8th 2022 but there are 584 other trials actively recruiting individuals right now."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger